Molecular basis of antibody binding to mucin glycopeptides in lung cancer

  • Authors:
    • Jin Qu
    • Hongtao Yu
    • Fenge Li
    • Chunlei Zhang
    • Ahmad Trad
    • Cory Brooks
    • Bin Zhang
    • Ting Gong
    • Zhi Guo
    • Yunsen Li
    • Govind Ragupathi
    • Yanyan Lou
    • Patrick Hwu
    • Wei Huang
    • Dapeng Zhou
  • View Affiliations

  • Published online on: December 18, 2015     https://doi.org/10.3892/ijo.2015.3302
  • Pages: 587-594
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glycopeptides bearing Tn epitopes are emerging targets for cancer diagnosis and immunotherapy. In this study, we analyzed membrane proteins containing O-glycosylated tandem repeat (TR) sequences in lung cancer patients of different types and stages, using gene microarray data in public domain. The expression of Tn and glycopeptide epitopes on the surface of lung cancer cell lines were studied by monoclonal IgG antibodies 14A, 16A, and B72.3. The binding of mAbs to synthetic glycopeptides were studied by surface plasmon resonance. Nine mucin mRNAs were found to be expressed in lung cancer patients but at similar level to healthy individuals. At protein level, a glycopeptide epitope on cancer cell surface is preferably recognized by mAb 16A, as compared to peptide-alone (14A) or sugar-alone epitopes (B72.3). 14A and 16A favor clustered TR containing more than three TR sequences, with 10-fold lower Kd than two consecutive TR. B72.3 preferrably recognized clustered sialyl-Tn displayed on MUC1 but not other O-glycoproteins, with 100-fold stronger binding when MUC1 is transfected as a sugar carrier, while the total sugar epitopes remain unchanged. These findings indicate that clusters of both TR backbones and sugars are essential for mAb binding to mucin glycopeptides. Three rules of antibody binding to mucin glycopeptides at molecular level are presented here: first, the peptide backbone of a glycopeptide is preferentially recognized by B cells through mutations in complementarity determining regions (CDRs) of B cell receptor, and the sugar-binding specificity is acquired through mutations in frame work of heavy chain; secondly, consecutive tandem repeats (TR) of peptides and glycopeptides are preferentially recognized by B cells, which favor clustered TR containing more than three TR sequences; thirdly, certain sugar-specific B cells recognize and accommodate clustered Tn and sialyl-Tn displayed on the surface of a mucin but not other membrane proteins.
View Figures
View References

Related Articles

Journal Cover

February-2016
Volume 48 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qu J, Yu H, Li F, Zhang C, Trad A, Brooks C, Zhang B, Gong T, Guo Z, Li Y, Li Y, et al: Molecular basis of antibody binding to mucin glycopeptides in lung cancer. Int J Oncol 48: 587-594, 2016.
APA
Qu, J., Yu, H., Li, F., Zhang, C., Trad, A., Brooks, C. ... Zhou, D. (2016). Molecular basis of antibody binding to mucin glycopeptides in lung cancer. International Journal of Oncology, 48, 587-594. https://doi.org/10.3892/ijo.2015.3302
MLA
Qu, J., Yu, H., Li, F., Zhang, C., Trad, A., Brooks, C., Zhang, B., Gong, T., Guo, Z., Li, Y., Ragupathi, G., Lou, Y., Hwu, P., Huang, W., Zhou, D."Molecular basis of antibody binding to mucin glycopeptides in lung cancer". International Journal of Oncology 48.2 (2016): 587-594.
Chicago
Qu, J., Yu, H., Li, F., Zhang, C., Trad, A., Brooks, C., Zhang, B., Gong, T., Guo, Z., Li, Y., Ragupathi, G., Lou, Y., Hwu, P., Huang, W., Zhou, D."Molecular basis of antibody binding to mucin glycopeptides in lung cancer". International Journal of Oncology 48, no. 2 (2016): 587-594. https://doi.org/10.3892/ijo.2015.3302